COMMUNIQUÉS West-GlobeNewswire
-
New Analysis of Over 50 Studies Showed that All the Non-Prescription CBD Products Researched Fell Short of Therapeutic Efficacy — Reinforcing the Case for Artelo's Optimized ART12.11 CBD Composition
22/07/2026 -
Unnatural Products Appoints Finance Leader Neera Ravindran, M.D., M.B.A., as Chief Financial Officer
22/07/2026 -
KC BioHub Awarded $38.1 Million to Advance Regional Biomanufacturing Growth
22/07/2026 -
BridgeBio Announces FDA Acceptance of NDA for Encaleret for ADH1
22/07/2026 -
Cannara Announces Normal Course Issuer Bid
22/07/2026 -
Guidelight Health Opens Eighth Massachusetts Location, Expanding Access to Structured Mental Health Care
22/07/2026 -
Pacira to Report Second Quarter 2026 Financial Results on Tuesday August 4, 2026
22/07/2026 -
Cannara annonce une offre publique de rachat dans le cours normal des activités
22/07/2026 -
VisiRose Selected to Present RB-PDAT at ESCRS iNovation® Day 2026 Emerging Company Showcase
22/07/2026 -
CMR Surgical and NVIDIA showcase future of intelligent surgery with Versius Plus™ at SRS 2026
22/07/2026 -
OKYO Pharma Announces Purchase of Shares by Chief Development Officer and Director
22/07/2026 -
Zevra Therapeutics Announces Details for Q2 2026 Financial Results Call
22/07/2026 -
Akari Therapeutics CEO Explains Why Growing Industry Demand for Next-Generation ADC Payloads Positions the Company at the Center of a Major Oncology Opportunity
22/07/2026 -
Med X Holdings Announces Official Name Change to Dazed Inc. and New Ticker Symbol "DAZD"
22/07/2026 -
Specialized Manufacturing Capability Emerges as the New Competitive Advantage in the $23.2 Billion Global Biologics CDMO Market, Finds Alira Health
22/07/2026 -
Monopar Initiates Rolling NDA Submission for ALXN1840 in Wilson Disease
22/07/2026 -
Inspire Medical Systems, Inc. Announces Retirement of Casey M. Tansey from its Board of Directors
22/07/2026 -
Oncotelic Announces Peer-Reviewed Publication Validating Deciparticle™ Technology Supporting the Ongoing Clinical Development of Sapu003 (IV everolimus)
22/07/2026 -
SoldierStrong Donates Two Real® Immersive Systems to Palo Alto VA to Advance Veteran Rehabilitation
22/07/2026
Pages